Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)
Titel:
Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)
Auteur:
Crumbaker, Megan Pathmanandavel, Sarennya Yam, Andrew O. Nguyen, Andrew Ho, Bao Chan, Lyn Ende, Jesse A. Rofe, Christopher Kongrak, Kamonwan Kwan, Edmond M. Azad, Arun A. Sharma, Shikha Pugh, Trevor J. Danesh, Arnavaz Keane, Joanne Eu, Peter Joshua, Anthony M. Emmett, Louise